Clin2
NCT07323446Possibly a fitNot yet recruiting

NAC for emotional dysregulation in children

Emotional Dysregulation

Treatments studied

Part of Mental health clinical trials.

This study tests whether N-acetylcysteine (NAC) can help children aged 6 to 12 with emotional dysregulation (severe mood swings, anxiety, or attention problems). It's a non-drug supplement that may improve brain function. The trial also includes a control group of typically developing kids for comparison.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
120 people
Ages
6 years to 12 years
Study type
Interventional

Who can take part

  • You are 6 to 12 years old.
  • You have severe emotional symptoms like anxiety, aggression, or trouble paying attention (based on a parent questionnaire).
  • You have access to a computer with a camera, speaker, microphone, and internet for study visits.
  • You agree not to change any current treatments during the study.
  • No history of seizures, serious medical conditions, or certain allergies to N-acetylcysteine.
  • If you are female and have started menstruating, you cannot participate.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07273695Recruiting
Real-world treatment effects for kids with ADHD or behavior issues

This study looks at how well treatments work in real life for children with ADHD, emotional outbursts, or behavior problems. It helps doctors understand what truly helps kids in daily life.

Bosisio Parini, Lecco
NCT05664789Recruiting· Phase 2/Phase 3
N-acetylcysteine for autism behaviors in children

This trial studies whether N-acetylcysteine, a medicine taken by mouth, can improve autism-related restricted and repetitive behaviors in children. It looks at children who are showing at least moderate severity in these behaviors and may involve brain testing for safety reasons.

Palo Alto, California
NCT07464886Recruiting· Phase 3
NAC and mindfulness therapy for depression in youth

This study tests whether a supplement called N-acetylcysteine (NAC) combined with a type of therapy called Mindfulness-Based Cognitive Therapy (MBCT) can help improve depression in teenagers and young adults. It looks at how these treatments affect brain chemicals and may reduce symptoms.

Cincinnati, Ohio
NCT05494398Enrolling by invitation· Phase 2/Phase 3
Testing N-acetylcysteine for autism symptoms

This study looks at whether N-acetylcysteine (NAC), a supplement/medication, can help autism-related symptoms by trying to target brain chemistry. You may be able to join if you previously took part in a related NAC study and can keep your usual medications steady.

Stanford, California
NCT04278898Recruiting· Phase 2
N-acetylcysteine to reduce repetitive behaviors in children with autism

This Phase 2 study tests whether a single dose of N-acetylcysteine can improve “restricted and repetitive behaviors” in children with autism. It’s meant for kids who are stable and still in early puberty stages.

Stanford, California
NCT04381897Not yet recruiting· Phase 2
N-acetylcysteine for repeated self-injury in Cornelia de Lange syndrome

This Phase 2 trial tests whether a supplement-like medicine called N-acetylcysteine (NAC) can reduce repetitive behaviors and self-injurious behaviors in people with Cornelia de Lange syndrome (CdLS). It also checks safety over about 18 weeks at Johns Hopkins Hospital.

Baltimore, Maryland

Hear when a new Emotional Dysregulation trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.